Altria Group Inc (MO) Stock News

Thermo Fisher Scientific unveiled the EMPAD G2 detector, enabling faster 4D STEM materials analysis at 10,000 frames per second with atomic-scale characterization. The detector integrates with Velox software for simplified analysis. The global 4D STEM market is projected to grow from $68 million in 2024 to $110 million by 2031 at a 6.6% CAGR, supporting TMO's growth prospects in analytical instruments.

Silicon Motion (SIMO) has received overwhelmingly bullish recommendations from Wall Street analysts with an average brokerage recommendation of 1.09 (Strong Buy), with 10 out of 11 firms rating it Strong Buy. The company's Zacks Rank #1 (Strong Buy) rating is supported by a 2.6% increase in consensus earnings estimates over the past month to $11.16 EPS, indicating growing analyst optimism about the company's earnings prospects.

The global MMORPG gaming market is projected to grow from $31.02 billion in 2026 to $51.3 billion by 2031 at a 10.58% CAGR. Growth is driven by smartphone adoption in emerging markets, 5G/cloud gaming technology, and free-to-play hybrid models with season passes. However, high development costs and regulatory scrutiny on loot boxes remain key challenges. Mobile platforms and Asia-Pacific regions are leading growth.

UMH Properties secured a new $10.2 million Fannie Mae mortgage at 6.03% fixed rate for a 267-site community through Wells Fargo. After paying off a $2.8 million existing mortgage, the company generated $7.4 million in additional proceeds to deploy toward acquisitions, expansions, rental homes, and debt repayment. The community has been improved from 69% to 95% occupancy since acquisition in 2014.

The Vanguard U.S. Momentum Factor ETF (VFMO) is a momentum-focused ETF holding nearly 700 U.S. stocks that have shown strong recent performance. The fund has outperformed both the Russell 3000 and S&P 500 benchmarks over many periods. A $10,000 investment could potentially grow to $96,500 over 20 years at a conservative 12% annual return, though past performance doesn't guarantee future results.

Rosen Law Firm reminds investors of Insulet Corporation who purchased securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks, resulting in investor damages.

Silicon Motion (SIMO) is displaying bullish technical indicators after crossing above its 20-day moving average and reaching a key support level. The stock has gained 25.5% over the past four weeks and holds a Zacks Rank #1 (Strong Buy) rating. Earnings estimate revisions have moved higher with 6 upward revisions and no downward revisions for the current fiscal year, suggesting potential for further gains.

Rosen Law Firm reminds investors of the August 10, 2026 deadline to join a securities class action lawsuit against ADMA Biologics. The lawsuit alleges the company made materially false statements regarding undisclosed related party transactions, channel stuffing, and inadequate internal controls that artificially inflated revenue during the class period from August 9, 2024 to March 25, 2026.

EXEED AiMOGA Robotics announced it has exceeded 2,000 cumulative global deliveries reaching over 60 countries and regions. The company is transitioning from product exports to scaled commercial deployment, with robots deployed in traffic management, medical guidance, and public services. EXEED is leveraging its parent company Chery's automotive industry expertise to support global expansion and is preparing to launch its VPD (Valet Parking Driver) technology in the Middle East.

A class action lawsuit has been filed against BitGo Holdings, Inc. (NYSE: BTGO) alleging that the company's IPO offering documents were negligently prepared and contained false or misleading statements. The lawsuit claims BitGo understated risks related to declining digital asset prices and lacked a reasonable basis for statements about its financial performance and business prospects. Investors who purchased BitGo securities between January 22, 2025 and May 13, 2026 have until August 7, 2026 to apply to be appointed as lead plaintiff.

Rosen Law Firm announces a securities class action lawsuit against Roblox Corporation, alleging the company made materially false and misleading statements about its organic growth potential. The lawsuit claims Roblox concealed that age verification rollout would cause significant growth slowdown, reduced on-platform communication, and declining app store ratings. The lead plaintiff deadline is August 7, 2026.

ADMA Biologics is facing a securities class action lawsuit alleging the company made false statements regarding undisclosed related party transactions, channel stuffing schemes, and inadequate internal controls. A Culper Research report claimed ADMA's reported 20% growth in 2025 was artificially inflated, with actual revenue declining 3% when adjusted for extended payment terms. The stock declined over 16% following the report, and an additional 13% after a Cantor Fitzgerald downgrade. Investors with substantial losses can seek lead plaintiff status by Monday, August 10, 2026.

Mowi ASA reported Q2 2026 harvest volumes across its global operations, with Norway leading at 85.0 thousand tonnes. The company announced a Share Purchase Agreement to divest its 9k GWT salmon farming operations in Canada East to Cooke Inc. for CAD 225 million on a debt-free basis.

Robbins Geller Rudman & Dowd LLP is seeking a lead plaintiff for a securities class action lawsuit against Erasca, Inc. The lawsuit alleges that Erasca made false and misleading statements regarding its ERAS-0015 drug candidate, including improper comparisons to competitor Revolution Medicines' technology and undisclosed patent infringement risks. Following disclosure of a patent infringement letter and adverse clinical trial data on April 27, 2026, Erasca's stock price fell approximately 59% combined. The deadline to apply as lead plaintiff is August 10, 2026.

A securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS) for allegedly making false statements about the Fabric acquisition's impact on the company's financials and operational efficiencies. The lawsuit claims defendants knew of significant problems with Fabric's viability that would negatively impact the business. Investors with losses exceeding $100K are encouraged to join the class action before the August 3, 2026 lead plaintiff deadline.

A class action lawsuit has been filed against Helen of Troy Limited for allegedly misleading investors about Project Pegasus, a restructuring initiative. The company claimed the project was delivering efficiencies and cost savings, but in reality lacked sufficient resources and budget. When the truth emerged in July 2024, the company reported a 49% EPS decline and cut full-year revenue guidance by over 20%, causing the stock to plummet 27.7%. Investors who purchased shares between April 24, 2024, and October 8, 2025, have until August 3, 2026, to apply as lead plaintiff.

Crédit Agricole du Morbihan, the leading bank in the Morbihan region, reported solid first-half 2026 results with net banking income up 6.0% to €152.5M and consolidated net profit up 15.8% to €57.8M. The bank gained 8,600 new customers and expanded its deposit base by 3.3% while maintaining strong capital ratios well above regulatory minimums. Credit activity remained resilient despite economic headwinds, with agricultural lending up 25.4%.

GeneDx Holdings Corp. (WGS) investors with substantial losses have until August 3, 2026 to seek appointment as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that GeneDx made false and misleading statements regarding the viability of its Fabric Genomics acquisition. GeneDx's stock dropped over 49% on May 4, 2026 after revealing a significant drop in adjusted gross margin from 74% to 69%, reduced earnings projections, and a $31.3 million impairment loss directly attributable to Fabric Genomics.

Digital Currency X Technology Inc. (Nasdaq: DCX) signed a non-binding memorandum of understanding with Whales AI Limited to commercialize an AI-powered STEM education robotics platform across the United States and Canada. DCX intends to invest US$20 million to support platform development and will serve as the exclusive territory agent, with revenue to be shared 60/40 (DCX/Whales AI). The agreement is subject to due diligence, final terms negotiation, and board approval, with no revenue expected in the current financial year.

EDMO announced the expansion of its System Intelligence layer, enabling universities to integrate AI products across CRM systems including Salesforce, Slate, HubSpot, and Zoho. The plug-and-play solution allows institutions to automate admissions workflows without data migration or replacing existing systems, while maintaining enterprise security compliance with SOC 2 Type II, FERPA, and GDPR standards.

OMODA & JAECOO held the 'OMODA SUPER AI NIGHT' event in Jakarta on July 27, 2026, marking the ASEAN regional debut of the OMODA 4 Cyber Mecha SUV. The event showcased the brand's AI cockpit technology powered by ByteDance's Seed large language model, positioning it as Southeast Asia's first vehicle-mounted solution with full native AI capabilities. The company announced expansion of its dealer and service network in Indonesia as part of its broader strategy to strengthen its presence in the intelligent mobility segment for young consumers across ASEAN markets.

A class action lawsuit has been filed against Zoetis, Inc. for allegedly making materially false statements and failing to disclose material adverse facts during the period from January 14, 2025 to May 6, 2026. The complaint alleges that Zoetis concealed weakening veterinarian adoption of its Librela product due to FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors have until July 27, 2026 to apply to be appointed as lead plaintiff.

IndiGo, India's largest airline, announced a record MoU with CFM International for 1,000+ LEAP-1A engines to power 510 Airbus A320neo Family aircraft. The deal includes CFM's support for establishing IndiGo's engine MRO facility and long-term material services. This marks the largest single LEAP engine order ever placed and strengthens the decade-long partnership between the companies.

Can-Fite BioPharma announced that its Phase 2a study results for Namodenoson in advanced pancreatic cancer patients have been accepted for poster presentation at ESMO Congress 2026. The study demonstrated durable disease stabilization and encouraging survival outcomes in third-line pancreatic cancer patients, with one patient remaining alive over 18 months after second-line treatment. The company plans to advance to a Phase 2b study combining Namodenoson with chemotherapy.

newcleo received a satisfactory safety opinion from French nuclear authority ASNR for its planned MOX fuel facility. The company has outgrown the France 2030 program scope due to significant capital raises and international expansion, including a planned NASDAQ listing via SPAC merger valuing it at $2.4 billion. France will continue supporting newcleo through licensing and regulatory assistance rather than direct funding.

Compass Therapeutics announced that its abstract for tovecimig, a DLL4 x VEGF-A bispecific antibody, has been accepted for an oral presentation at the ESMO Congress 2026 in Madrid. The presentation will showcase Phase 2/3 COMPANION-002 trial results evaluating tovecimig combined with paclitaxel in patients with advanced biliary tract cancer, to be presented by Dr. Nilofer Azad from Johns Hopkins University on October 24, 2026.

Chevron to sign MOUs with Iraq for West Qurna 2 and Nassiriya oilfields  Reuters

Robbins Geller is seeking a lead plaintiff for a securities fraud class action lawsuit against Sportradar Group AG. The lawsuit alleges that Sportradar made false statements about its compliance practices and intentionally worked with black-market gambling operators. Following investigative reports published on April 22, 2026, Sportradar's stock fell over 22%. Investors with substantial losses have until July 17, 2026 to apply for lead plaintiff status.

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false and misleading statements regarding revenue and cost recording. The company allegedly overstated revenue, assets, and accounts receivable due to deficient internal controls, requiring financial statement restatement. Investors who purchased Veritone securities between October 14, 2025 and April 14, 2026 have until July 20, 2026 to apply as lead plaintiff.

The global oligonucleotide contract development and manufacturing organization (CDMO) market is experiencing strong growth driven by expanding RNA-targeted medicine pipelines, increased outsourcing of complex synthesis and manufacturing, and rising demand for precision medicine. The market is projected to grow at a 21.81% CAGR through 2031, with contract manufacturing leading at 51.68% market share in 2025. Antisense oligonucleotides dominate at 58.23% revenue, while siRNA is the fastest-growing segment at 23.25% CAGR. Asia-Pacific is the fastest-growing region at 24.56% CAGR, driven by capacity expansion in China, South Korea, and Japan.